Clinical Trial Update: Study TO Prevent Diabetes With Short-term Insulin Glargine Only [NA]

View source ↗

Summary

This clinical trial update discusses a study investigating whether short-term insulin glargine can prevent progression to diabetes in people with prediabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Beijing Tongren Hospital | Conditions: Pre-diabetes | NA | Status: UNKNOWN